Claudette Faucher-Charles
Nurse Practitioner · Richmond
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 11 years
- Graduated 2015
Offices
1 location · Supportive Care of Vermont LLC · 4 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Claudette Faucher-Charles’s office at (718) 298-4375 to ask if they take your plan before you enroll.
Original Medicare doctor bills
$104,838
Medicare paid this office $104,838 for 406 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 285 | $73,190 | $77 |
| Initial nursing facility care with high level of medical decision making, per day 50 minutes or more | 160 | $20,748 | $130 |
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 22 | $5,060 | $110 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 46 | $3,523 | $53 |
| Initial nursing facility care with moderate level of medical decision making, per day at least 35 minutes | 20 | $1,906 | $95 |
Who their Medicare patients are
406 Original Medicare patients in 2024. Average age 81 · Under 65 6% · 85 and older 35% · Women 58% · Also on Medicaid 48% · Health risk score 2.35. Above the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 75% · Depression 69% · Dementia 53% · Chronic kidney disease 51% · Heart failure 50% · Diabetes 47% · Coronary heart disease 39% · Atrial fibrillation 36% · COPD 32% · Stroke 26% · Cancer 16%.
The office billed $236,935, Medicare allowed $130,313 and paid $104,838; for 1,248 services of 7 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 406 | 1,248 | 81 | 2.35 | $236,935 | $104,838 |
| 2023 | 220 | 711 | 79 | 2.00 | $131,053 | $56,205 |
| 2022 | 694 | 774 | 72 | 0.92 | $31,553 | $18,131 |
| 2021 | 559 | 798 | 71 | 0.89 | $143,139 | $35,724 |
| 2020 | 187 | 294 | 71 | 1.35 | $77,709 | $17,315 |
| 2019 | 155 | 187 | 70 | 2.05 | $66,932 | $15,155 |
| 2018 | 87 | 104 | 70 | 1.77 | $33,367 | $6,940 |
| 2017 | 139 | 237 | 70 | 1.59 | $49,781 | $14,906 |
| 2016 | 122 | 223 | 70 | 1.65 | $34,579 | $14,477 |
| 2015 | 117 | 261 | 72 | 1.07 | $13,560 | $12,252 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 179 | $43,847 | $74 |
| Initial nursing facility care with high level of medical decision making, per day 50 minutes or more | 57 | $7,083 | $124 |
| Residence visit for established patient with moderate level of medical decision making, per day at least 40 minutes | 12 | $1,622 | $90 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 15 | $1,038 | $52 |
2022: 1 service
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 678 | $16,379 | $22 |
2021: 7 services
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 148 | $7,748 | $51 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 282 | $6,529 | $22 |
| New patient visit (15+ min) | 88 | $5,999 | $68 |
| New patient visit (30+ min) | 65 | $5,969 | $92 |
| Short return visit (20+ min) | 58 | $4,382 | $74 |
| Short return visit | 64 | $3,571 | $53 |
| Automated urinalysis test | 20 | $45 | $2 |
2020: 8 services
| New patient visit (30+ min) | 51 | $4,634 | $91 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 50 | $2,771 | $51 |
| New patient visit (15+ min) | 37 | $2,528 | $68 |
| Return visit (30+ min) | 26 | $2,285 | $82 |
| Short return visit (20+ min) | 29 | $1,693 | $56 |
| Short return visit | 27 | $1,178 | $41 |
| New patient visit (10+ min) | 21 | $887 | $42 |
| Automated urinalysis test | 13 | $32 | $2 |
2019: 6 services
| New patient visit (45+ min) | 40 | $4,361 | $109 |
| New patient visit (30+ min) | 28 | $2,187 | $78 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 19 | $1,884 | $99 |
| Return visit (30+ min) | 24 | $1,823 | $73 |
| Short return visit (20+ min) | 28 | $1,630 | $51 |
| Short return visit | 12 | $399 | $33 |
2018: 5 services
| New patient visit (45+ min) | 15 | $1,793 | $120 |
| Return visit (30+ min) | 17 | $1,251 | $74 |
| Short return visit (20+ min) | 21 | $904 | $43 |
| New patient visit (30+ min) | 15 | $851 | $57 |
| Short return visit | 11 | $322 | $27 |
2017: 5 services
| New patient visit (30+ min) | 42 | $2,785 | $66 |
| Short return visit (20+ min) | 43 | $2,307 | $45 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $1,963 | $52 |
| Hospital discharge day management, more than 30 minutes | 16 | $1,237 | $77 |
| Return visit (30+ min) | 14 | $782 | $52 |
2016: 4 services
| Return visit (30+ min) | 41 | $3,684 | $74 |
| New patient visit (30+ min) | 35 | $2,665 | $76 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $2,617 | $51 |
| Short return visit (20+ min) | 28 | $1,701 | $52 |
2015: 4 services
| Pneumococcal vaccine, 13-valent | 35 | $5,939 | $170 |
| Influenza vaccine split virus, preservative free | 77 | $2,565 | $33 |
| Administration of influenza virus vaccine | 83 | $1,708 | $21 |
| Administration of pneumococcal vaccine | 35 | $720 | $21 |
Medicaid work
$2,891 in 2024
Medicaid paid $2,891 for 489 billed services this clinician did in 2024, up to 54 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ NURSING FACILITY CARE MOD MDM 30 MINUTES | 489 | $2,891 |
| 2024 | 489 | 1 | 54 | $2,891 |
| 2023 | 582 | 1 | 55 | $10,526 |
| 2022 | 2,472 | 5 | 617 | $27,723 |
| 2021 | 3,944 | 7 | 542 | $105,713 |
| 2020 | 985 | 6 | 97 | $21,196 |
See the largest Medicaid services in earlier years
2023
| SBSQ NURSING FACILITY CARE MOD MDM 30 MINUTES | 582 | $10,526 |
2022
| OFF/OP EST MAY X REQ PHY/QHP | 2,220 | $26,513 |
| SARSCOV CORONAVIRUS AG IA | 21 | $604 |
| Short return visit (20+ min) | 15 | $497 |
| Service(s) provided in the office during regularly scheduled evening, weekend, or holiday office hours, in addition to basic service | 12 | $76 |
| Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 204 | $32 |
2021
| Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), amplified probe technique | 1,125 | $41,826 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 542 | $19,813 |
| OFF/OP EST MAY X REQ PHY/QHP | 1,244 | $15,671 |
| Short return visit | 574 | $12,427 |
| Short return visit (20+ min) | 264 | $8,947 |
| New patient visit (30+ min) | 156 | $7,028 |
| Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 39 | $0 |
2020
| Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), amplified probe technique | 433 | $10,206 |
| New patient visit (30+ min) | 72 | $3,112 |
| Short return visit | 209 | $2,808 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 134 | $2,177 |
| OFFICE/OUTPATIENT VISIT NEW | 113 | $2,087 |
| Short return visit (20+ min) | 24 | $806 |
Drugs they prescribed that Part D paid
$10,828
Pharmacies billed $10,828 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 102) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
91 generic and fewer than 11 brand-name prescriptions · $10,828 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Montelukast | 12 | $389 | $32 |
Year by year
| 2024 | 102 | 22 | 0% (0) | None | $10,828 |
| 2023 | 401 | 59 | None | None | $52,620 |
| 2022 | 115 | 38 | 10% (11) | None | $17,830 |
| 2021 | 135 | 99 | None | None | $2,148 |
| 2020 | 179 | 102 | None | None | $3,956 |
| 2019 | 181 | 64 | 10% (18) | 7% | $4,556 |
| 2018 | 214 | 59 | 18% (38) | None | $3,233 |
| 2017 | 146 | 64 | 25% (36) | None | $2,171 |
| 2016 | 99 | 51 | 24% (24) | 15% | $4,457 |
| 2015 | 16 | 13 | 0% (0) | 0% | $148 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Gabapentin | 29 | $583 | $20 |
| Atorvastatin | 24 | $273 | $11 |
| Levothyroxine | 12 | $268 | $22 |
| Potassium Chloride | 11 | $217 | $20 |
| Losartan | 11 | $144 | $13 |
2021: 2 drugs
| Cephalexin | 17 | $61 | $4 |
| Prednisone | 15 | $36 | $2 |
2020: 5 drugs
| Proctosol-Hc | 11 | $723 | $66 |
| Neomycin Sulfate | 29 | $127 | $4 |
| Metronidazole | 31 | $73 | $2 |
| Gabapentin | 11 | $56 | $5 |
| Prednisone | 11 | $35 | $3 |
2019: 8 drugs
| Proctosol-Hc | 13 | $592 | $46 |
| Diphenoxylate-Atropine | 14 | $412 | $29 |
| Ondansetron Odt | 15 | $292 | $19 |
| Metronidazole | 30 | $190 | $6 |
| Ciprofloxacin | 12 | $163 | $14 |
| Gabapentin | 17 | $108 | $6 |
| Neomycin Sulfate | 21 | $90 | $4 |
| Tramadol | 12 | $39 | $3 |
2018: 6 drugs
| Diphenoxylate-Atropine | 15 | $763 | $51 |
| Ondansetron Odt | 22 | $278 | $13 |
| Gabapentin | 35 | $234 | $7 |
| Metronidazole | 28 | $201 | $7 |
| Neomycin Sulfate | 22 | $95 | $4 |
| Tramadol | 30 | $93 | $3 |
2017: 4 drugs
| Ondansetron Odt | 38 | $888 | $23 |
| Metronidazole | 20 | $84 | $4 |
| Tramadol | 23 | $73 | $3 |
| Neomycin Sulfate | 14 | $57 | $4 |
2016: 2 drugs
| Ondansetron Odt | 19 | $934 | $49 |
| Oxycodone | 15 | $73 | $5 |
Money from drug and device companies
$308 in 2024
| 2024 | 2 | 3 | None | $308 |
| 2023 | 1 | 2 | None | $183 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Otsuka America Pharmaceutical | Rexulti | $183 | 2 payments
|
| Neurocrine Biosciences | Ingrezza | $125 | 1 payment
|
See all 3 published payments
| Neurocrine Biosciences | Meals · 2024-05-21 | Ingrezza | $125 |
| Otsuka America Pharmaceutical | Meals · 2024-04-30 | Rexulti | $111 |
| Otsuka America Pharmaceutical | Meals · 2024-02-27 | Nuedexta | $72 |
See earlier years (2023)
2023: $183
| ACADIA Pharmaceuticals | Nuplazid | $183 | 2 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 89.4 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1124403415
- Licence
- CT 6183
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X)
- Mailing address
- 508 Shem Butler Ct, Charleston, SC, 29414
- NPI first listed
- 2015-07-28
- NPI last updated
- 2026-03-09
- NPI record certified
- 2026-03-09
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1 Lawson Ln Ste 200d, Burlington, VT, 05401 · 4000 Faber Place Dr Ste 300, Charleston, SC, 29405 · 325 N Saint Paul St Ste 3100, Dallas, TX, 75201 · 100 Pearl St Fl 14, Hartford, CT, 06103 · 500 Ala Moana Blvd Ste 7400, Honolulu, HI, 96813 · 1 Gateway Ctr Ste 2600, Newark, NJ, 07102 · 195 Page Mill Rd Ste 103, Palo Alto, CA, 94306 · 10 Dorrance St Ste 700, Providence, RI, 02903